PathAI Publications

AI-powered FOLR1 Scoring Shows High Concordance with Manual Evaluation in High-Grade Serous Ovarian Carcinoma

Written by Admin | Sep 12, 2026, 1:00:00 PM

Study Background


Folate receptor alpha (FOLR1) is a clinically actionable biomarker in ovarian carcinoma, with immunohistochemistry (IHC) used to identify patients eligible for targeted therapies. However, manual scoring is semi-quantitative and subject to interobserver variability, particularly in cases near the clinical decision threshold. IHCExplore* (PathAI, Boston, MA) is an AI-powered tool for tissue segmentation and cell-level IHC quantification. We evaluated the concordance between AI-derived and manual FOLR1 scoring.

IHCExplore is For Research Use Only. Not for use in diagnostic procedures.

Conference

European Congress of Pathology

View Poster